http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007010973-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a3d769ec1031b59fcca3c151074a3a9d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_56560534bef2b97b29fe78b1d71326db
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_31e61ca22e796a1735f0c4a63f9bd38d
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7004
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L1-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H3-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7004
filingDate 2006-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c8abeedb9c19b402f5248b7cfb88f5f2
publicationDate 2007-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2007010973-A1
titleOfInvention Utilization of anti-neuropathic pain effect of d-allose and d-psicose
abstract [PROBLEMS] To control neuropathic pain produced by various mechanisms. [MEANS FOR SOLVING PROBLEMS] Disclosed is a composition for elimination, relief or reduction of neuropathic pain comprising, as an active ingredient, at least one substance selected from the group consisting of D-allose, a derivative of D-allose, D-psicose and a derivative of D-psicose preferably in an amount of 0.01 to 90% by weight. The composition may comprise a mixture of D-allose and/or a derivative thereof and D-psicose and/or a derivative thereof at a ratio of 1:1 to 10:1. The neuropathic pain may be one induced by a disease selected from the group consisting of trigeminal neuralgia, postoperative pain, periodontitis, gingivitis, gingivostomatitis, oral ulcer, herpes zoster, postherpetic neuralgia, diabetic neuritis, causalgia, phantom limb pain and malignant tumor. Also disclosed is use of the composition for elimination, relief or reduction of neuropathic pain by administering the composition to a patient with neuropathic pain in such an amount that 0.01 to 100 g of the at least one substance can be taken by the patient per day.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021193659-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106535661-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106535661-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2017526651-A
priorityDate 2005-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2005263744-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2003529570-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9109604-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2004537494-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03097820-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006093292-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2005263734-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127796643
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439507
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53782691
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226423049
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226442279
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226422718
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID102288
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID90008

Total number of triples: 43.